60 likes | 441 Views
Gary Simon David Parenti Carmen Tuazon Afsoon Roberts Angelike Liappis . Fred Gordin Virginia Kan Cynthia Gibert Debra Benator Anne Labriola. Division of Infectious Diseases Department of Medicine. GWU Hospital 371 beds 15,000 admissions/yr VAMC Hospital 120 beds.
E N D
Gary Simon David Parenti Carmen Tuazon Afsoon Roberts Angelike Liappis Fred Gordin Virginia Kan Cynthia Gibert Debra Benator Anne Labriola Division of Infectious DiseasesDepartment of Medicine Division of Infectious Diseases
GWU Hospital 371 beds 15,000 admissions/yr VAMC Hospital 120 beds Medical Faculty Associates (MFA) Ambulatory Care Building (ACC) 280 physicians 41 medical specialties 1,500 patients/day HIV/AIDS Clinical Services Division of Infectious Diseases
HIV/AIDS Clinical Services • Infectious Diseases Clinic • Outpatient management of antiretroviral therapy (ARVT) • Treatment of naïve and ARVT experienced 800 HIV/AIDS patients at GWU • 30% women • 50% African American • 15% Hepatitis C co-infection • 12% Hepatitis B co-infection • 800 HIV/AIDS patients at the VAMC • Opportunistic infection therapy/prevention Division of Infectious Diseases
GWU/MFA Clinical Trials Unit (CTU) Three FT study coordinators Suzanne Schuck, RN MPH Nicole Bisby Aimee Desrosiers, PAC MPH Phlebotomy lab, two – 80˚C freezers, adjacent to clinic Investigator-initiated projects and Phase I-IV clinical trials ID Research Laboratory Ross 705 Bona Yoon, research associate Translational projects VAMC Clinical Trials Unit (CPCRA) VA Research Laboratory Clinical applications and translational research projects Flow cytometry/CD4 HIV quantitation by bDNA assay HIV genotypic resistance testing HCV quantitation HCV genotyping by real-time PCR HIV/AIDS Clinical Services Division of Infectious Diseases
HIV/AIDS Clinical Services • Infectious Diseases Clinic • Active HIV/AIDS research initiatives • Studies involving: new drugs/drug classes, vaccines, immunomodulating therapies • Pro-atherogenic potential of antiretroviral drugs (R01 HL65955) • Immune reconstitution mediated events, opportunistic infection • Propose new bedside-to-bench initiatives: host and viral factors affecting viral load and the response to therapy • New programs being developed • Application October, 2006 Ryan White funding • Expanding the treatment of infectious hepatitis Division of Infectious Diseases
HIV/AIDS Clinical Services • ID Hospital consultation service • ~ 100 consultations/month • ~ 50% of consults for HIV/AIDS, all services • Majority are for the management of complications of untreated or undiagnosed HIV/AIDS • New programs being developed • Determining barriers to healthcare access for hospitalized patients with end-stage HIV/AIDS • Predictors of non-compliance with clinical follow-up after hospitalization Division of Infectious Diseases